CD4 T cell phenotype after AS01-adjuvanted immunization is shaped by prior antigen or pathogen exposure

Area of Science:

• Immunology
• Vaccinology

Background:

• CD4 T-cell responses are vital for vaccine-induced protection.
• Adjuvants like AS01 can improve vaccine effectiveness.
• AS01 is used in vaccines for zoster, RSV, malaria, and tuberculosis.

Purpose of the Study:

• To understand how pre-existing immune memory influences vaccine-induced CD4 T-cell responses.
• To elucidate the drivers of polyfunctional CD4 T-cell phenotypes.

Main Methods:

• Analysis of CD4 T-cell responses from clinical trials of AS01-adjuvanted vaccines.
• Evaluation across diverse populations with varying immune priming levels.

Main Results:

• A consistent pattern showed that prior exposure levels correlated with interferon-γ production by antigen-specific CD4 T cells.
• Pre-existing memory T cells appear critical for this response.

Conclusions:

• Host immune memory significantly shapes vaccine-induced CD4 T-cell responses.
• Understanding immune priming is key for developing next-generation vaccines tailored to specific populations.